Published on FiercePharma (http://www.fiercepharma.com)

J&J nabs Topamax patent extension

By tracy

Created Jul 25 2008 - 8:52am

Johnson & Johnson's epilepsy med Topamax won't go off patent in September as scheduled because the FDA has extended market exclusivity for one year based on a new pediatric indication for the med. Report [1]

Johnson & Johnson
patent expirations
Topamax

Source URL: http://www.fiercepharma.com/story/j-j-nabs-topamax-patent-extension/2008-07-25

Links:
[1] http://www.forbes.com/feeds/ap/2008/07/24/ap5252557.html